JY
RLAY icon

Jeff Yass’s Relay Therapeutics RLAY Stock Holding History

Jeff Yass’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$844K Buy
+45,100
New +$655K ﹤0.01% 8623
2026
Q1 		– Sell
-28,600
Closed -$242K – 13957
2025
Q4 		$242K Buy
+28,600
New +$204K ﹤0.01% 10446
2025
Q2 		– Sell
-17,500
Closed -$45.9K – 13564
2025
Q1 		$45.9K Buy
17,500
+6,300
+56% +$24.7K ﹤0.01% 11893
2024
Q4 		$46.1K Sell
11,200
-11,200
-50% -$60.9K ﹤0.01% 11711
2024
Q3 		$159K Buy
22,400
+5,000
+29% +$37.4K ﹤0.01% 10689
2024
Q2 		$113K Buy
+17,400
New +$119K ﹤0.01% 10930
2023
Q3 		– Sell
-53,100
Closed -$667K – 12818
2023
Q2 		$667K Sell
53,100
-55,300
-51% -$688K ﹤0.01% 7633
2023
Q1 		$1.79M Buy
+108,400
New +$1.94M ﹤0.01% 5389
2022
Q4 		– Sell
-65,600
Closed -$1.47M – 13483
2022
Q3 		$1.47M Buy
+65,600
New +$1.44M ﹤0.01% 5655
2022
Q2 		– Sell
-49,300
Closed -$1.48M – 13790
2022
Q1 		$1.48M Sell
49,300
-45,000
-48% -$1.09M ﹤0.01% 6175
2021
Q4 		$2.9M Buy
94,300
+61,100
+184% +$1.93M ﹤0.01% 4712
2021
Q3 		$1.05M Buy
+33,200
New +$1.12M ﹤0.01% 7436

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jeff Yass's RLAY Position: Q2 2026 in Review

Jeff Yass reduced its Relay Therapeutics (RLAY) stake by 34% in Q2 2026, selling an estimated $735K and leaving 96,549 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #6725.

Jeff Yass first reported a position in RLAY in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.2M in Q1 2023. 257 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jeff Yass held 96,549 shares of Relay Therapeutics worth $1.81M as of Q2 2026.
  • Jeff Yass sold 50,609 Relay Therapeutics shares in Q2 2026, an estimated $735K.
  • Relay Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6725 holding.
  • Jeff Yass first reported a position in Relay Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Jeff Yass's Relay Therapeutics position peaked at $4.2M in Q1 2023.
  • 257 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.